Drug Shortage Report for TARO-CALCIPOTRIOL / BETAMETHASONE GEL
| Report ID | 175749 |
| Drug Identification Number | 02525178 |
| Brand name | TARO-CALCIPOTRIOL / BETAMETHASONE GEL |
| Common or Proper name | CB GEL |
| Company Name | TARO PHARMACEUTICALS INC |
| Market Status | MARKETED |
| Active Ingredient(s) | BETAMETHASONE CALCIPOTRIOL |
| Strength(s) | 0.5MG 50MCG |
| Dosage form(s) | GEL |
| Route of administration | TOPICAL |
| Packaging size | 60 |
| ATC code | D05AX |
| ATC description | ANTIPSORIATICS FOR TOPICAL USE |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2022-11-14 |
| Estimated end date | 2023-08-18 |
| Actual end date | 2023-07-18 |
| Shortage status | Resolved |
| Updated date | 2023-07-19 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 130 EAST DRIVE BRAMPTON, ONTARIO CANADA L6T 1C1 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v1 | 2022-11-25 | English | Compare |